Peptides DB
Research-centric peptide and protocol reference hub
Study 19 of 22Tesofensine literatureAntibiotics (Basel, Switzerland) · Observational2026

Occurrence of Phenotypic Multidrug-Resistant <i>E. coli</i> in Kentucky (USA) Surface Waters and Exploration of Sentinel Antibiotics for One Health Surveillance.

MDR E. coli was found in Kentucky surface waters, with 25% showing resistance from tetracycline-treated media, raising concerns for public health surveillance.

Read at Antibiotics (Basel, Switzerland)Add to compare

Where it sits

this study against the rest of the tesofensine corpus
7
Preclinical
14
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study measured the occurrence of multidrug-resistant (MDR) E. coli in surface waters of Kentucky, focusing on non-susceptibility to tetracycline. Samples were collected from 47 sites between 2022 and 2024. The findings indicated a significant prevalence of MDR phenotypes among the isolates.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
100% TE non-susceptibility in E. coli from TE-treated media.2026

Abstract

The authors’ words, as Antibiotics (Basel, Switzerland) supplied them

<b>Background/Objectives</b>: Antimicrobial resistance (AMR) is a global public health threat, and surface waters may serve as surveillance locations for multidrug-resistant (MDR) bacteria within communities. This study explored MDR <i>E. coli</i> in Kentucky (USA) surface waters, primarily evaluating non-susceptibility to tetracycline, for assessing MDR associations. <b>Methods</b>: Surface water samples were collected from 47 sites in East-Central Kentucky during 2022 and 2024. Isolates were obtained using selective differential media, with and without tetracycline (TE) supplementation, targeting <i>E. coli</i> and TE-resistant <i>E. coli.</i> Species identification and antimicrobial susceptibility testing against 21 antibiotics representing 13 categories was performed with recovered presumptive <i>E. coli</i> isolates. MDR was defined as non-susceptibility to at least one antibiotic in three or more antimicrobial categories. <b>Results</b>: Of 151 isolates, 130 (86%) were identified as <i>E. coli</i>. Overall, 25% and 13% of recovered <i>E. coli</i> isolates from media with and without TE had MDR phenotypes, respectively, which included one isolate with non-susceptibility to 10 of 12 designated antibiotic categories. MDR prevalence was higher among incidentally recovered <i>Enterobacter</i> spp. (100%) than <i>E. coli</i>. TE non-susceptibility occurred in 100% and 18% of <i>E. coli</i> isolates recovered from TE-treated and untreated media, respectively. Ampicillin non-susceptibility occurred in 28% and 16% of <i>E. coli</i> isolates from TE-treated and untreated media. Among this non-random set of recovered isolates, ampicillin and cefazolin non-susceptibility demonstrated potential for MDR <i>E. coli</i> prediction. TE-treated media did not significantly improve MDR <i>E. coli</i> recovery. <b>Conclusions</b>: MDR <i>E. coli</i> and one potentially extensively drug-resistant (XDR) <i>E. coli</i> isolate were recoverable from Kentucky surface waters. Ampicillin and cefazolin non-susceptibility demonstrated potential as sentinel markers for informing screening media development for AMR surveillance in Kentucky waters.

Elsewhere in the Tesofensine corpus

CEnsemble Docking, MD, and MM/PBSA Identify Flavonoids as Putative Modulators of EFNB2/B3-Nipah Virus G Interaction.International journal of molecular sciences · 2026 · Not reported in abstract.In vitroCA tomato MIK2-clade receptor is involved in the perception of a Fusarium-derived elicitor.The New phytologist · 2026 · Not reported in abstract.In vitroBLong COVID symptom profiles, workforce participation, and working hours among adults in England: a population-based cohort study.The Lancet regional health. Europe · 2026 · Adjusted odds ratio [aOR]: 0.62, 95% CI: 0.55, 0.70 for being in paid work with unresolved Long COVID.HumanDMDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights.Movement disorders clinical practice · 2026 · SPRS scores increased with increasing age at examination after the age of 40 years.reviewCDesign and computational evaluation of &lt;i&gt;E&lt;/i&gt;-stilbene-bearing 1,3,4-oxadiazole derivatives as potential tyrosinase inhibitors using DFT, molecular docking and ADMET studies.RSC advances · 2026 · IC50 values of 0.32 ± 0.03 µM and 0.76 ± 0.01 µM for compounds 5d and 5b, respectively.In vitroBStructural brain alterations in chronic primary pain: a multimodal MRI study.NeuroImage. Clinical · 2026 · n=60 · Increased gyrification in left prefrontal regions in CPP patients.Human